(Q37362674)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19124392%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19124392%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19124392%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

Christoph Schindler

1 reference

19 August 2017

publication date

1 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19124392%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic advances in cardiovascular disease

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19124392%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19124392%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19124392%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

7-26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19124392%20AND%20SRC:MED&resulttype=core&format=json

Anti-inflammatory effects of short-term pioglitazone therapy in men with advanced diabetic nephropathy

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Association between plasma renin activity and metabolic cardiovascular risk factors in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Therapeutic options for modifying cardiometabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

PPAR dual agonists: are they opening Pandora's Box?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

PPAR delta: a dagger in the heart of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The G972R variant of the insulin receptor substrate-1 (IRS-1) gene, body fat distribution and insulin-resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hyperten

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Essential hypertension: renin and aldosterone, heart attack and stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Increased activity of endogenous endothelin in patients with type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Weight gain as a risk factor for clinical diabetes mellitus in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Plasma triglyceride level and mortality from coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The Gly16-->Arg16 and Gln27-->Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Diabetes mellitus and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

PPARs and the complex journey to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Metabolic syndrome: a solution in search of a problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The metabolic syndrome, hyperlipidemia, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Increasing prevalence of the metabolic syndrome among u.s. Adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The Q121 PC-1 variant and obesity have additive and independent effects in causing insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The key role of insulin resistance in the cardiometabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The cardiometabolic syndrome as a cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Monogenic forms of insulin resistance: apertures that expose the common metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

High triglycerides and low HDL cholesterol and blood pressure and risk of ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Rats with low brain angiotensinogen do not exhibit insulin resistance during early aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monother

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Regional adiposity and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Metabolic syndrome pathophysiology: the role of adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Adipokines: molecular links between obesity and atheroslcerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Recent advances in our understanding of insulin action and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Transcriptional repression of atherogenic inflammation: modulation by PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Body weight and mortality. A 27-year follow-up of middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Insulin blunts sympathetic vasoconstriction through the alpha 2-adrenergic pathway in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Insulin resistance in essential hypertension is related to plasma renin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Effect of Rosiglitazone Treatment on Soluble CD40L in Patients With Type 2 Diabetes and Coronary Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Evidence for a potent antiinflammatory effect of rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The metabolically obese, normal-weight individual revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Review: Insulin and endothelin: an interplay contributing to hypertension development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Insulin, nitric oxide and the sympathetic nervous system: at the crossroads of metabolic and cardiovascular regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Effect of elevated triglyceride levels on endothelium-dependent vasodilation in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Angiotensin blockade prevents type 2 diabetes by formation of fat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Is there a rationale for angiotensin blockade in the management of obesity hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension*

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Prevalence of impaired glucose tolerance among children and adolescents with marked obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Effects of calcium antagonists on insulin sensitivity and other metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Update on the cardiometabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Diabetes, hypertension, and cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Adiponectin and cardiovascular disease: state of the art?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Ethnic differences in abdominal visceral fat accumulation between Japanese, African-Americans, and Caucasians: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Adverse endothelial function and the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Association of fasting blood sugar level, insulin level, and obesity with left ventricular mass in healthy children and adolescents: The Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Cross-talk between the insulin and angiotensin signaling systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Obesity and the metabolic syndrome in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

The metabolic syndrome: practical guide to origins and treatment: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Insulin modulates circulating endothelin-1 levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Hypertriglyceridemia: its etiology, effects and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Atherogenesis: a postprandial phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Global and societal implications of the diabetes epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Metabolic Syndrome and Early Death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

Premature Atherosclerosis in Patients with Familial Chylomicronemia Caused by Mutations in the Lipoprotein Lipase Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662

High Prevalence of Insulin Resistance and Metabolic Syndrome in Overweight/Obese Preadolescent Hong Kong Chinese Children Aged 9-12 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944707082662